Clinical Trial

Study of CM310 in Adolescent Subjects With Atopic Dermatis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a multi-center, single arm, open label phase 3 study to evaluate the safety and efficacy of CM310 in children patients with moderate-to-severe atopic dermatitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-02.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-27
Trial Details
NCT Number NCT06495229
Lead Sponsor Keymed Biosciences Co.Ltd
Conditions Atopic Dermatitis
Enrollment 180 participants
Start Date 2024-08-02
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-02